nach oben

International Journal of Mental Health and Addiction

Erschienen in:

01.01.2008

Development of ASI Psychiatric Severity Cut-Off Scores To Identify Co-Occurring Psychiatric Disorders

verfasst von: John S. Cacciola, Anna Pecoraro, Arthur I. Alterman

Erschienen in: International Journal of Mental Health and Addiction | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

This study empirically evaluates the value of the psychiatric section of the Addiction Severity Index (ASI) as a screening instrument for non-substance use Axis-I psychiatric disorders. Data were from a diverse sample of 672 recently admitted patients to inpatient, residential, and outpatient substance abuse treatment. ASI psychiatric summary scale scores and SCID-III-R results were subjected to Receiver Operating Characteristics analyses to determine how well the ASI identified participants with/out a co-occurring psychiatric disorder. Diagnostic detection using the ASI psychiatric scales was good: ASI Interviewer Severity Ratings (ISRs) yielded 81% sensitivity and 53% specificity (C = 0.73); ASI Clinical Factors (CFs), 85% sensitivity and 55% specificity (C = 0.78); ASI Composite Scores (CSs), 80% sensitivity and 60% specificity (C = 0.76); ASI Evaluation Indices (EIs), 80% sensitivity and 60% specificity (C = 0.75). Separate analyses by gender generated very similar results. Clinical implications and applications as well as further research directions are discussed.

Alterman, A. I., McDermott, P. A., Cook, T., Cacciola, J. S., McKay, J. R., McLellan, A. T., et al. (2000). Generalizability of the clinical dimensions of the Addiction Severity Index to nonopiate dependent patients. Psychology of Addictive Behaviors, 14, 287–294.PubMedCrossRef

Alterman, A. I., McDermott, P. A., Cook, T. G., Metzger, D., Rutherford, M. J., Cacciola, J. S., et al. (1998). New scales to assess change in the Addiction Severity Index for the opioid, cocaine, and alcohol dependent. Psychology of Addictive Behaviors, 12(4), 233–246.CrossRef

Alterman, A. I., Bovasso, G. B., Cacciola, J. S., & McDermott, P. A. (2001a). A comparison of the predictive validity of four sets of baseline ASI summary indices. Psychology of Addictive Behaviors, 15(2), 156–162.CrossRef

Alterman, A. I., Mulvaney, F. D., Cacciola, J. S., Cnaan, A., McDermott, P. A., & Brown, L. (2001b). The validity of interviewer severity ratings in groups of ASI interviewers with varying training. Addiction, 96, 1297–1305.PubMedCrossRef

American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed.) Revised. Washington, D.C.: American Psychiatric Association.

American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed). Washington, DC.: American Psychiatric Association.

American Psychiatric Association. (2006). Practice guideline for the treatment of patients with substance use disorders (2nd ed.). American Psychiatric Association.

Bartels, S. J., Drake, R. E., & Wallach, M. A. (1995). Long-term course of substance use disorders among patients with severe mental illness. Psychiatric Services, 46, 248–251.PubMed

Battisti, F., De Franciscis, A., Tarsitani, L., Di Clemente, L., Di Stani, F., Calabresi, M., et al. (2004). Gender differences in anger, depression and anxiety dimensions and psychometric screening of psychopathology in a sample of students. Rivista di Psichiatria, 39(3), 184–188.

Beck, A. T., Ward, C., & Mendelson, M. (1961). Beck depression inventory. Archives of General Psychiatry, 4, 561–571.PubMed

Brown, R. A., Monti, P. M., Myers, M. G., Martin R. A., Rivinus T., Dubreuil, M. E. (1998). Depression among cocaine abusers in treatment: Relation to cocaine and alcohol use and treatment outcome. American Journal of Psychiatry, 155, 220–225.PubMed

Bultler, S. F., Budman, S. H., Goldman, R. J., Newman, F. J., Beckley, K. E., Trottier, D., et al. (2001). Initial validation of a computer-administered Addiction Severity Inventory: The ASI-MV. Psychology of Addictive Behaviors, 15(1), 4–12.CrossRef

Cacciola, J. S, Alterman, A. I., McKay, J. R., & Rutherford, M. J. (2001a). Psychiatric comorbidity in patients with substance use disorders: Do not forget Axis II disorders. Psychiatric Annals, 31(5), 321–331.

Cacciola, J. S., Alterman, A. I., Rutherford, M. J., McKay, J., & Mulvaney, F. D. (2001b). The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug and Alcohol Dependence, 61, 271–280.PubMedCrossRef

Cacciola, J., & Dugosh, K. (2003). Co-occurring substance use and mental disorders: A literature review. Document prepared by DeltaMetrics under contract for the Center for Substance Abuse Treatment. Fairfax, VA: Caliber Associates.

Cacciola, J. S., Rutherford, M. J., Alterman, A. I., McKay, J. R., & Mulvaney, F. D. (1999). Long-term test–retest reliability of personality disorder diagnoses in opiate dependent patients. Journal of Personality Disorders, 12, 332–337.

Calsyn, D. A., Saxon, A. J., Bush, K. R., Howell, D. N., Baer, J. S., Sloan, K. L., et al. (2004). The Addiction Severity Index medical and psychiatric composite scores measure similar domains as the SF-36 in substance-dependent veterans: Concurrent and discriminant validity. Drug and Alcohol Dependence, 76, 165–171.PubMedCrossRef

Carey, K. B., Cocco, K. M., & Correia, C. J. (1997). Reliability and validity of the Addiction Severity Index among outpatients with severe mental illness. Psychological Assessment, 9(4), 422–428.CrossRef

Carroll, K. M., Power, M. E., Bryant, K., & Rounsaville, B. J. (1993). One-year follow-up status of treatment-seeking cocaine abusers: Psychopathology and dependence severity as predictors of outcome. Journal of Nervous and Mental Disease, 181, 71–79.PubMed

Center for Substance Abuse Treatment. (2006a). Overarching principles to address the needs of persons with co-occurring disorders. COCE Overview Paper 3. DHHS Publication No. (SMA) 06-4165. Rockville, MD: Substance Abuse and Mental Health Services Administration.

Center for Substance Abuse Treatment. (2006b). Definitions and terms relating to co-occurring Disorders. COCE Overview Paper 1. DHHS Publication No. (SM) 06-4163. Rockville, MD: Substance Abuse and Mental Health Services Administration and Center for Mental Health Services.

Clements, R., & Heintz, J. M. (2002). Diagnostic accuracy and factor structure of the AAS and APS scales of the MMPI-2. Journal of Personality Assessment, 79, 564–582.PubMedCrossRef

Compton, W. M., Cottler, L. B., Jacobs, J. L., Ben-Abdallah, A., & Spitznagel, E. L. (2003). The role of psychiatric disorders in predicting drug dependence treatment outcomes. American Journal of Psychiatry, 160, 890–895.PubMedCrossRef

Cottler, L. B., Schuckit, M. A., Helzer, J. E., Crowley, T. J., Woody, G., Nathan, P., et al. (1995). The DSM-IV field trial for substance use disorders: Major results. Drug and Alcohol Dependence, 38, 59–69.PubMedCrossRef

Davis, R. D., & Millon, T. (1999). Models of personality and its disorders. In T. Millon, P. H. Blaney, & R. D. Davis, (Eds.), Oxford textbook of psychopathology (pp. 485–522). New York: Oxford University Press.

Derogatis, L. R., & Cleary, P. A. (1977). Confirmation of the dimensional structure of the SCL-90: A study in construct validation. Journal of Clinical Psychology, 33(4), 981–989.CrossRef

Drake, R. E., McHugo, G. J., & Biesanz, J. C. (1995). The test–retest reliability of standardized instruments among homeless persons with substance use disorders. Journal of Studies on Alcohol, 56, 161–167.PubMed

Drake, R. E., Yovetich, N. A., Bebout, R. R., Harris, M., & McHugo, G. J. (1997). Integrated treatment for dually diagnosed homeless adults. Journal of Nervous and Mental Disease, 185(5), 298–305.PubMedCrossRef

Ebert, M. H., Loosen, P. T., & Nurcombe, B. (2003). Chapter 18. Substance-related disorders. In Current diagnosis and treatment in psychiatry. New York: McGraw Hill Medical.

Eland-Goossensen, A., Van de Goor, I., Garretsen, H., & Schudel, J. (1997). Screening for psychopathology in the clinical practice. Journal of Substance Abuse Treatment, 14(6), 585–591.PubMedCrossRef

Eysenck, H. J. (1959). Maudsley personality inventory. London, England: University of London Press LTD.

Fawcett, T. (2004). ROC graphs: Notes and practical considerations for researchers (HP Labs Tech Report HPL-2003-4). Palo Alto, CA: Hewlett Packard Laboratories.

Frank, E. (Ed). (2000). Gender and its effects on psychopathology. American Psychopathological Association series (pp. 61–84). Washington, DC: American Psychiatric. XVI, 315 pp.

Franken, I. H., & Hendriks, V. M. (2001). Screening and diagnosis of anxiety and mood disorders in substance abuse patients. The American Journal on Addictions, 10, 30–39.PubMedCrossRef

Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., et al. (2004a). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related conditions. Archives of General Psychiatry, 61, 807–816.PubMedCrossRef

Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Ruan, W. J., & Pickering, R. P. (2004b). Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 61, 361–368.CrossRef

Grella, C. E., & Stein, J. A. (2006). Impact of program services on treatment outcomes of patients with comorbid mental and substance use disorders. Psychiatric Services, 57(7), 1007–1015.PubMedCrossRef

Hamilton, M. (1967). Development of a rating scale for primary depressive illness. British Journal of Social Clinical Psychology, 6, 278–298.

Harris, K. M., & Edlund, M. J. (2005). Use of mental health care and substance abuse treatment among adults with co-occurring disorders. Psychiatric Services, 56(8), 954–959.PubMedCrossRef

Hasin, D., Liv, X., Nunes, E., McCloud, S., Samet, S., & Endicott, J. (2002). Effects of major depression on remission and relapse of substance dependence. Archives of General Psychiatry, 59, 375–380.PubMedCrossRef

Hendriks, V. M., Kaplan, C.D., van Limbeek, J., & Geerlings, P. (1989). The Addiction Severity Inventory: Reliability and validity in a Dutch addict population. Journal of Substance Abuse Treatment, 6, 133–141.PubMedCrossRef

Herman, S. E., Frank, K. A., Mowbray, C. T., Ribisl, K. M., Davidson, W. S. 2nd, BootsMiller, B., et al. (2000). Longitudinal effects of integrated treatment on alcohol use for persons with serious mental illness and substance use disorders. Journal of Behavioral Health Services Research, 27, 286–302.PubMedCrossRef

Hodgins, D. C., & El-Guebaly, N. (1992). More data on the Addiction Severity Inventory: Reliability and validity with the mentally ill substance abuser. The Journal of Nervous and Mental Disease, 180, 197–201.PubMed

Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., Eshleman, S., et al. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Archives of General Psychiatry, 51, 8–19.PubMed

Kessler, R. C., Nelson, C. B., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996). The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. American Journal of Orthopsychiatry, 66(1), 17–31.PubMedCrossRef

Kleinman, P. H., Miller, A. B., Millman, R. B., Woody, G. E., Todd, T., Kemp, J., et al. (1990). Psychopathology among cocaine abusers entering treatment. Journal of Nervous and Mental Disease, 178(7), 442–447.PubMedCrossRef

Kokotailo, P. K., Egan, J., Gangnon, R., Brown, D., Mundt, M., & Fleming, M. (2004). Validity of the alcohol use disorders identification test in college students. Alcoholism: Clinical and Experimental Research, 28, 914–920.

Kosten, T. R., Rounsaville, B., & Kleber, H. D. (1983). Concurrent validity of the Addiction Severity Inventory. Journal of Nervous and Mental Disease, 171, 606–610.PubMed

Kranzler, H. R., Kadden, R. M., Babor, T. F., Tennen, H., & Rounsaville, B. J. (1996). Validity of the SCID in substance abuse patients. Addiction, 91(6), 859–868.PubMedCrossRef

Lehman, A. F., Myers, C. P., Dixon, L. B., & Johnson, J. L. (1996). Detection of substance use disorders among psychiatric inpatients. Journal of Nervous and Mental Disease, 184, 228–233.PubMedCrossRef

Leonhard, C., Mulvey, K., Gastfriend, D. R., & Schwartz, M. (2000). The Addiction Severity Inventory: A field study of internal consistency and validity. Journal of Substance Abuse Treatment, 18(2), 129–135.PubMedCrossRef

Loong, T. (2003). Understanding sensitivity and specificity with the right side of the brain. British Medical Journal, 327, 716–719.PubMedCrossRef

Mäkelä, K. (2004). Studies of the reliability and validity of the Addiction Severity Index. Addiction, 99, 398–410.PubMedCrossRef

McDermott, P. A., Alterman, A. I., Brown, L., & Zabellero, A. (1996). Construct refinement and confirmation for the Addiction Severity Inventory. Psychological Assessment, 8(2), 182–189.CrossRef

McKay, J. R., Alterman, A. I., McLellan, A. T., Boardman, C. R., Mulvaney, F. D., & O’Brien, C. P. (1998). Random versus nonrandom assignment in the evaluation of treatment for cocaine abusers. Journal of Consulting and Clinical Psychology, 66, 697–701.PubMedCrossRef

McLellan, A. T., Cacciola, J. S., & Alterman, A. I. (2004). Commentaries on Mäkelä: The ASI as a still developing instrument: Response to Mäkelä. Addiction, 99(4), 411–412.CrossRef

McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., et al. (1992). The fifth edition of the Addiction Severity Inventory. Journal of Substance Abuse Treatment, 9, 199–213.PubMedCrossRef

McLellan, A. T., Luborsky, L., Cacciola, J., & Griffith, J. E. (1985). New data from the Addiction Severity Inventory: Reliability and validity in three centers. The Journal of Nervous and Mental Disease, 173, 412–423.PubMedCrossRef

McLellan, A. T., Luborsky, L., O’Brien, C. P., & Woody, G. E. (1980). An improved diagnostic instrument for substance abuse patients: The Addiction Severity Inventory. Journal of Nervous and Mental Disease, 168, 26–33.PubMedCrossRef

McLellan, A. T., Luborsky, L., Woody, G. E., O’Brien, C. P., Druley, K. A. (1983a). Predicting response to alcohol and drug abuse treatments: Role of psychiatric severity. Archives of General Psychiatry, 40, 620–625.PubMed

McLellan, A. T., Woody, G. E., Luborsky, L., O’Brien, C. P., & Druley, K. A. (1982). Is treatment for substance abuse effective? Journal of the American Medical Association, 247, 1423–1427.PubMedCrossRef

McLellan, A. T., Woody, G. E., Luborsky, L., O’Brien, C. P., & Druley, K. A. (1983b). Increased effectiveness of substance abuse treatment: A prospective study of patient-treatment “matching.” Journal of Nervous and Mental Disease, 171, 597–605.PubMed

Metz, C. E. (1978). Basic principles of ROC analysis. Seminars in Nuclear Medicine, 8(4), 283–298.PubMedCrossRef

Moos, R. H., Finney, J. W., Federman, E. B., & Suchinsky, R. (2000). Specialty mental health care improves patients’ outcomes: Findings from a nation-wide program to monitor the quality of care for patients with substance use disorders. Journal of Studies on Alcohol, 61, 704–713.PubMed

National Association of State Mental Health Program directors & National Association of State Alcohol and Drug Abuse Directors. (1998). National dialogue on co-occurring mental health and substance abuse disorders. Washington, DC: National Association of State Alcohol and Drug Abuse Directors. Retrieved January 11, 2007, from http://www.nasadad.org/Departments/Research/ConsensusFramework/national_dialogue_on.htm.

Office of Applied Studies. (2005). Results from the 2004 National Survey on Drug Use and Health: National findings (DHHS Publication No. SMA 05-4062, NSDUH Series H-28). Rockville, MD: Substance Abuse and Mental Health Services Administration.

Ouimette, P. C., Moos, R. H., & Finney, J. W. (2000). Two-year mental health service use and course of remission in patients with substance use and posttraumatic stress disorders. Journal of Studies on Alcohol, 61, 247–253.PubMed

Project MATCH Research Group. (1997). Matching alcoholism treatments to patient heterogeneity: Project match posttreatment drinking outcomes. Journal of Studies on Alcohol, 58, 7–29.

Ray, G. T., Weisner, C. M., & Mertens, J. R. (2005). Relationship between use of psychiatric services and five-year alcohol and drug treatment outcomes. Psychiatric Services, 56, 164–171.PubMedCrossRef

Regier, D. A., Farmer, M., Rae, D., Locke, B., Keith, S., Judd, L., et al. (1990). Comorbidity of mental disorders with alcohol and other drug abuse: Results from the epidemiologic catchment area (ECA) study. Journal of the American Medical Association, 264, 2511–2518.PubMedCrossRef

Rikoon, S. H., Cacciola, J. S., Carise, D., Alterman, A. I., & McLellan, A. T. (2006). Predicting DSM-IV dependence diagnoses from the Addiction Severity Inventory. Journal of Substance Abuse Treatment, 31, 17–24.PubMedCrossRef

Ritsher, J. B., McKellar, J. D., & Finney, J. W. (2002). Psychiatric comorbidity, continuing care, and mutual help as predictors of five-year remission from substance use disorders. Journal of Studies on Alcohol, 63, 709–715.PubMed

Robins, L. N., Witchen, H. U., Helzer, J. E., Babor, T. F., Burke, J., Farmer, A., et al. (1989). The Composite international diagnostic interview: An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Archives of General Psychiatry, 45, 1069–1077.

Rounsaville, B. J., Anton, S. F., Carroll, K., Budde, D., Prusoff, B. A., & Gawin, F. (1991). Psychiatric diagnoses of treatment-seeking cocaine abusers. Archives of General Psychiatry, 48, 43–51.PubMed

Rounsaville, B. J., Dolinsky, Z. S., Babor, T. F., & Meyer R. E. (1987). Psychopathology as a predictor of treatment outcome in alcoholics. Archives of General Psychiatry, 44, 505–513.PubMed

Rounsaville, B. J., Kosten, T. R., Weissman, M. M., & Kleber, H. D. (1986). Prognostic significance of psychopathology in treated opiate addicts: A 2.5 year follow-up study. Archives of General Psychiatry, 43, 739–745.PubMed

Rumpf, H. J., Hapke, U., Meyer, C., & John, U. (2002). Screening for alcohol use disorders and at-risk drinking in the general population: Psychometric performance of three questionnaires. Alcohol and Alcoholism, 37, 261–268.PubMedCrossRef

Shear, M., Greeno, C., Kang, J., Ludewig, D., Frank, E., Swartz, H. A., et al. (2000). Diagnosis of nonpsychotic patients in community clinics. American Journal of Psychiatry, 157, 581–587.PubMedCrossRef

Skyre, I. O., Torgersen, S., & Kringlen, E. (1991). High interrater reliability for the structured clinical interview for DSM-III-R Axis I (SCID-I). Acta Psychiatrica Scandanavia, 2(84), 167–173.CrossRef

Spielberger, C. D., Gorsuch, R. L., Lushene, P. R., Vagg, P. R., & Jacobs, A. G. (1983). Manual for the State-Trait Anxiety Inventory (Form Y). Palo Alto: Consulting Psychologists.

Spitzer, R. L., Endicott, J., & Robins, E. (1975). Research Diagnostic Criteria (RDC). New York: Biometrics Research, New York State Psychiatric Institute.

Spitzer, R. L, Williams, J., Gibbon, M., & First, M. B. (1990). Structured Clinical Interview for DSM-III-R, Patient Edition/Non-patient Edition, (SCID-P/SCID-NP). Washington, D.C.: American Psychiatric.

Steiner, J. L., Tebes, J. K., Sledge, W. H, & Walker, M. L. (1995). A comparison of the Structured Clinical Interview for DSM-III-R and clinical diagnoses. Journal of Nervous and Mental Disease, 183(6), 365–369.PubMed

Stoffelmayr, B. E., Mavis, B. E., & Kasim, R. M. (1994). The longitudinal stability of the Addiction Severity Inventory. Journal of Substance Abuse Treatment, 11(4), 373–378.PubMedCrossRef

Swets, J. A. (1992). The science of choosing the right decision threshold in high-stakes diagnostics. American Psychologist, 47, 522–532.PubMedCrossRef

Swets, J. A., Dawes, R. M., & Monahan, J. (2000). Psychological science can improve diagnostic decisions. Psychological Science in the Public Interest, 1(1), 1–26.CrossRef

Swindle, R. W., Phibbs, C. S., Paradise, M. J., Recine, B. P., & Moos, R. H. (1995). Inpatient treatment for substance abuse patients with psychiatric disorders: A national study of determinants of readmission. Journal of Substance Abuse, 7, 79–97.PubMedCrossRef

Ware, J. E., Kosinski, M. A., & Keller, S. D. (1994). SF-36 physical and mental component summary measures: A User’s manual. Boston: The Health Institute of New England Medical Center.

Watkins, K. E., Hunter, S. B., Burnam, M. A., Pincus, H. A., & Nicholson, G. (2005). Review of treatment recommendations for persons with a co-occurring affective or anxiety and substance use disorder. Psychiatric Services, 56(8), 913–926.PubMedCrossRef

Weisner, C., Matzger, H., & Kaskutas, L. A. (2003). How important is treatment? One-year outcomes of treated and untreated alcohol-dependent patients. Addiction, 98, 901–911.PubMedCrossRef

Williams, J. B., Gibbon, M., First, M. B., Spitzer, R. L., Davis, M., Borus, J., et al. (1992). The structured clinical interview for DSM-III-R (SCID) II. Multi-site test–retest reliability. Archives of General Psychiatry, 49, 630–636.

Winkler, D., Pjrek, E., Heiden, A., Wieseger, G., Klein, N., Konstantinidis, A., et al. (2004). Gender differences in the psychopathology of depressed inpatients. European Archives of Psychiatry and Clinical Neuroscience, 254(4), 209–214.PubMed

Zanarini M. C., & Frankenburg, F. R. (2001). Attainment and maintenance of reliability of Axis I and Axis Ii disorders over the course of a longitudinal study. Comprehensive Psychiatry, 42(5), 369–374.PubMedCrossRef

Zanis, D. A., McLellan, A. T., Cnaan, R. A., & Randall, M. (1994). Reliability and validity of the Addiction Severity Index with a homeless sample. Journal of Substance Abuse Treatment, 11(6), 541–548.PubMedCrossRef

Ziedonis, D. M., & Kosten, T. R. (1991). Depression as a prognostic factor for pharmacologic treatment of cocaine dependence. Psychopharmacology Bulletin, 27, 337–343.PubMed

Titel: Development of ASI Psychiatric Severity Cut-Off Scores To Identify Co-Occurring Psychiatric Disorders
verfasst von: John S. Cacciola
Anna Pecoraro
Arthur I. Alterman
Publikationsdatum: 01.01.2008
Verlag: Springer-Verlag
Erschienen in: International Journal of Mental Health and Addiction / Ausgabe 1/2008
Print ISSN: 1557-1874
Elektronische ISSN: 1557-1882
DOI: https://doi.org/10.1007/s11469-007-9103-7

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2008

Audience Discussion

Screening and Assessment of Personality Disorders in Addiction Treatment Settings

Remembering Olabisi

Screening and Treating Mental Disorders in Addiction Treatment Settings: A Stepped Care Model